TFEB and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease models, ouabain demonstrates neuroprotective effects by activating a signaling pathway that stimulates transcription factor EB (TFEB), a key regulator of gene transcription within the autophagy–lysosome system, thus reducing tau levels in APP mice [187].